{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:20:16Z","timestamp":1790436016306,"version":"4.1.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100010120","name":"Huashan Hospital","doi-asserted-by":"crossref","award":["2016QD079"],"award-info":[{"award-number":["2016QD079"]}],"id":[{"id":"10.13039\/501100010120","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) associated with bladder cancer (BCa) risk in Caucasian and East Asian population. The objective of this study was to validate these SNPs in Chinese population and evaluate whether these SNPs could differentiate the individual inherited risk for BCa.<\/jats:p>\n            <jats:p>A case-control study including 581 BCa cases and 1561 healthy controls was performed. Germline DNA samples from all individuals were genotyped for eight SNPs. Genetic risk score (GRS) was calculated for each individual based on the odds ratios and risk allele frequencies of five risk-associated SNPs.<\/jats:p>\n            <jats:p>Among eight SNPs evaluated in this study, rs798766 at 4p16.3 [OR\u200a=\u200a1.39 (1.15\u20131.67), <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001], rs9642880 [OR\u200a=\u200a1.17 (1.06\u20131.30), <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001] and rs4813953 at 20p12.2 [OR\u200a=\u200a1.09 (1.02\u20131.17), <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.016] were found associated with BCa risk in Chinese population. A genetic risk score was established based on five SNPs (including the above three SNPs and two other SNPs which have the consistent direction with previous reported genome-wide association study). The mean GRS was significantly higher in BCa cases than controls (1.22 vs. 1.01, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). When subjects were categorized into low- (&lt;0.8), average- (0.8\u20131.2), and high-risk (&gt;1.2) groups, the likelihoods of BCa were 25.2%, 33.7% and 55.0%, respectively (<jats:italic toggle=\"yes\">P<\/jats:italic>-trend\u200a&lt;\u200a2.2\u200a\u00d7\u200a10<jats:sup>\u221216<\/jats:sup>). In subgroup analyses, no significant difference was observed in mean GRS among BCa patients with different stages or grades.<\/jats:p>\n            <jats:p>In conclusion, two SNPs derived from East Asian and one SNP from Caucasian were associated with BCa risk in Chinese population. These results provided additional information of genetic risks for BCa in Chinese population. Genetic risk score based on these SNPs can reveal inherited risk of BCa, and may have potential for modifying personalized cancer screening strategy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000019980","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:36:13Z","timestamp":1588970173000},"page":"e19980","source":"Crossref","is-referenced-by-count":6,"title":["Genetic risk scores based on risk-associated single nucleotide polymorphisms can reveal inherited risk of bladder cancer in Chinese population"],"prefix":"10.1097","volume":"99","author":[{"given":"Chenyang","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Urology"},{"name":"Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Lin","sequence":"additional","affiliation":[{"name":"Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Na","sequence":"additional","affiliation":[{"name":"Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Yu","sequence":"additional","affiliation":[{"name":"Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifei","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Urology"},{"name":"Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowen","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Urology"},{"name":"Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zujun","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Urology"},{"name":"Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Lilly","family":"Zheng","sequence":"additional","affiliation":[{"name":"Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Urology"},{"name":"Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishuo","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Urology"},{"name":"Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, PR China"},{"name":"Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Urology"},{"name":"Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Xu","sequence":"additional","affiliation":[{"name":"Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, PR China"},{"name":"Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,5]]},"reference":[{"key":"R1-20240308","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R2-20240308","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40880-015-0001-2","article-title":"Annual report on status of cancer in China, 2011","volume":"27","author":"Chen","year":"2015","journal-title":"Chin J Cancer Res"},{"key":"R3-20240308","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","article-title":"Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018","volume":"74","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"key":"R4-20240308","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s10654-016-0138-6","article-title":"Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses","volume":"31","author":"Al-Zalabani","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"R5-20240308","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0022-5347(05)65520-6","article-title":"Familial bladder cancer in the National Swedish Family Cancer Database","volume":"166","author":"Plna","year":"2001","journal-title":"J Urol"},{"key":"R6-20240308","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2015.17703","article-title":"Familial risk and heritability of cancer among twins in nordic countries","volume":"315","author":"Mucci","year":"2016","journal-title":"JAMA"},{"key":"R7-20240308","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.canep.2017.03.003","article-title":"Family history of cancer and the risk of bladder cancer: A case\u2013control study from Italy","volume":"48","author":"Turati","year":"2017","journal-title":"Cancer Epidemiol"},{"key":"R8-20240308","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/ng.558","article-title":"A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer","volume":"42","author":"Kiemeney","year":"2010","journal-title":"Nat Genet"},{"key":"R9-20240308","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/ng.229","article-title":"Sequence variant on 8q24 confers susceptibility to urinary bladder cancer","volume":"40","author":"Kiemeney","year":"2008","journal-title":"Nat Genet"},{"key":"R10-20240308","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1093\/hmg\/ddu264","article-title":"Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer","volume":"23","author":"Rafnar","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R11-20240308","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/carcin\/bgr060","article-title":"Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population","volume":"32","author":"Wang","year":"2011","journal-title":"Carcinogenesis"},{"key":"R12-20240308","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1002\/cam4.2143","article-title":"Systematic evaluation of cancer-specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts","volume":"8","author":"Shi","year":"2019","journal-title":"Cancer Med"},{"key":"R13-20240308","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/ijc.28898","article-title":"Cumulative effect of genome-wide association study-identified genetic variants for bladder cancer","volume":"135","author":"Wang","year":"2014","journal-title":"Int J Cancer"},{"key":"R14-20240308","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/jnci\/djh075","article-title":"Assessing the probability that a positive report is false: an approach for molecular epidemiology studies","volume":"96","author":"Wacholder","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R15-20240308","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/gim.2016.103","article-title":"Personalized risk prediction for type 2 diabetes: the potential of genetic risk scores","volume":"19","author":"Lall","year":"2017","journal-title":"Genet Med"},{"key":"R16-20240308","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11892-017-0961-5","article-title":"Genetic risk scores for type 1 diabetes prediction and diagnosis","volume":"17","author":"Redondo","year":"2017","journal-title":"Curr Diab Rep"},{"key":"R17-20240308","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.atherosclerosis.2017.01.010","article-title":"A 45-SNP genetic risk score is increased in early-onset coronary artery disease but independent of familial disease clustering","volume":"257","author":"Christiansen","year":"2017","journal-title":"Atherosclerosis"},{"key":"R18-20240308","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/CIRCULATIONAHA.115.020109","article-title":"Incorporating a genetic risk score into coronary heart disease risk estimates: effect on low-density lipoprotein cholesterol levels (the MI-GENES Clinical Trial)","volume":"133","author":"Kullo","year":"2016","journal-title":"Circulation"},{"key":"R19-20240308","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4103\/1008-682X.182981","article-title":"Clinical validity and utility of genetic risk scores in prostate cancer","volume":"18","author":"Helfand","year":"2016","journal-title":"Asian J Androl"},{"key":"R20-20240308","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1158\/1940-6207.CAPR-17-0141","article-title":"Inclusion of a genetic risk score into a validated risk prediction model for colorectal cancer in Japanese men improves performance","volume":"10","author":"Iwasaki","year":"2017","journal-title":"Cancer Prev Res (Phila)"},{"key":"R21-20240308","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw302","article-title":"Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers","volume":"109","author":"Kuchenbaecker","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"R22-20240308","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jnci\/djx237","article-title":"Familial cancer clustering in urothelial cancer: a population-based case\u2013control study","volume":"110","author":"Martin","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"R23-20240308","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1158\/1055-9965.EPI-10-0763","article-title":"Risk of urinary bladder cancer is associated with 8q24 variant rs9642880[T] in multiple racial\/ethnic groups: results from the Los Angeles-Shanghai case-control study","volume":"19","author":"Cortessis","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R24-20240308","doi-asserted-by":"crossref","first-page":"7850708","DOI":"10.1155\/2017\/7850708","article-title":"Association between the TACC3 rs798766 polymorphism and risk of urinary bladder cancer: a synthesis based on current evidence","volume":"2017","author":"Meng","year":"2017","journal-title":"Dis Markers"},{"key":"R25-20240308","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/hmg\/ddt519","article-title":"Genome-wide association study identifies multiple loci associated with bladder cancer risk","volume":"23","author":"Figueroa","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R26-20240308","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1200\/JCO.2005.05.1771","article-title":"Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas","volume":"24","author":"Hernandez","year":"2006","journal-title":"J Clin Oncol"},{"key":"R27-20240308","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.eururo.2007.12.026","article-title":"Prediction of progression of non\u2013muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study","volume":"54","author":"Burger","year":"2008","journal-title":"Eur Urol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019980","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T20:15:34Z","timestamp":1709928934000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":27,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000019980","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}